GHRP Peptide 2 (10 mg) OxyPharma

Catalogue entry: GHRP Peptide 2 (10 mg) OxyPharma. Labelled content: 10 mg. Listed pack: 1 vial. The amount identifies labelled product content, not an administration dose.

Identity and mechanism

GHRP-2 is a synthetic growth-hormone-releasing peptide acting through the ghrelin-receptor system. It belongs to a receptor pathway also studied with GHRP-6, Ipamorelin and Hexarelin. Similar target terminology does not establish equal hormone selectivity, appetite effects or duration of exposure.

What the research measured

Laferrère and colleagues examined GHRP-2 and food intake in human studies published in 2005 and 2006. Chihara and colleagues studied its diagnostic endocrine use in 2007. These designs document specific appetite or hormone responses. Diagnostic stimulation testing and short metabolic experiments are different from trials of muscle gain or improved recovery in athletes.

Sporting claims and limitations

In sport, interest in raising GH can obscure other endocrine effects. Research comparisons have included cortisol and prolactin responses as well as GH. Appetite changes and downstream glucose regulation are relevant to interpretation; a higher laboratory value cannot by itself establish a favourable overall outcome. Findings for Hexarelin or another secretagogue should not be borrowed as evidence for this exact product.

Product identity and documentation

The selected label quantity is not a clinical-use instruction. Product assessment needs a clear GHRP-2 identity, relevant chemical-form information and a lot-specific analytical report. Pack contents, concentration where applicable and manufacturer traceability should agree across the label and documents. A source claim of purity alone does not establish composition, sterility or equivalence to material used in diagnostic research.